Testing effectiveness (Phase 2)Study completedNCT03754582What this trial is testingIntravenous Perampanel in Japanese Participants With EpilepsyWho this might be right forEpilepsySeizures Eisai Co., Ltd. 21
Not applicableLooking for participantsNCT05673915What this trial is testingStudy of Transcranial Direct Current Stimulation to Treat EpilepsyWho this might be right forFocal EpilepsyGeneralized Onset EpilepsySleep-related Epileptic Encephalopathy Mayo Clinic 30
Large-scale testing (Phase 3)WithdrawnNCT00175864What this trial is testingOpen Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.Who this might be right forEpilepsy UCB Pharma
Large-scale testing (Phase 3)Study completedNCT01243177What this trial is testingTrial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and OlderWho this might be right forEpilepsyMonotherapy UCB BIOSCIENCES GmbH 888
Testing effectiveness (Phase 2)Study completedNCT00175929What this trial is testingBrivaracetam in Subjects With Partial Onset SeizuresWho this might be right forEpilepsy, Focal UCB Pharma 157
Not applicableStudy completedNCT06960811What this trial is testingEpileptic Psychoses and Their Link With Ictal Emotions and ConsciousnessWho this might be right forEpilepsy With Partial Onset Seizures With or Without Secondary GeneralizationPsychosesEpilepsy, Generalized Central Hospital, Nancy, France 117
Large-scale testing (Phase 3)Study completedNCT01465997What this trial is testingEvaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and OlderWho this might be right forEpilepsyMonotherapy UCB BIOSCIENCES GmbH 551
Large-scale testing (Phase 3)Looking for participantsNCT04274179What this trial is testingKetogenic Diet for New-Onset Absence EpilepsyWho this might be right forAbsence EpilepsyKetogenic DietingEpilepsy, Absence Johns Hopkins University 40
Not applicableStudy completedNCT00006176What this trial is testingClinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion BodiesWho this might be right forFamilial Dementia With Neuroserpin Inclusion BodiesNervous System Heredodegenerative Disorder National Human Genome Research Institute (NHGRI) 100
Testing effectiveness (Phase 2)Looking for participantsNCT06908356What this trial is testingAn Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresWho this might be right forFocal Onset SeizurePrimary Generalized Epilepsy Praxis Precision Medicines 50
Post-approval studies (Phase 4)Study completedNCT00266604What this trial is testingEvaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyWho this might be right forEpilepsySeizuresEpilepsies, Partial+2 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 409
Not applicableStudy completedNCT04252846What this trial is testingInvestigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized EpilepsyWho this might be right forIdiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures Eisai Limited 191
Early research (Phase 1)Looking for participantsNCT06700811What this trial is testingKetogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic EpilepsiesWho this might be right forDevelopmental and Epileptic EncephalopathiesEpileptic SpasmsGenetic Epilepsy+1 more Heather Olson 10
Large-scale testing (Phase 3)Study completedNCT00236886What this trial is testingProspective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsWho this might be right forEpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49
Testing effectiveness (Phase 2)Study completedNCT00152451What this trial is testingStudy With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset SeizuresWho this might be right forEpilepsy, Partial UCB S.A. - Pharma Sector 31
Testing effectiveness (Phase 2)Study completedNCT00175825What this trial is testingA Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.Who this might be right forEpilepsy UCB Pharma 210
Not applicableNo Longer AvailableNCT03559673What this trial is testingCompassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic SeizuresWho this might be right forEpilepsies, Partial UCB Biopharma S.P.R.L.
Large-scale testing (Phase 3)Study completedNCT01463306What this trial is testingA 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic SeizuresWho this might be right forEpilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Not applicableActive Not RecruitingNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Large-scale testing (Phase 3)WithdrawnNCT00175851What this trial is testingOpen Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of EpilepsyWho this might be right forEpilepsy UCB Pharma